Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - bisacodyl 5mg - enteric coated tablet - 5 mg - active: bisacodyl 5mg excipient: carnauba wax hyprolose hypromellose methacrylic acid copolymer eudragit l 100 iron oxide yellow isopropyl alcohol lactose monohydrate magnesium stearate   methacrylic acid copolymer microcrystalline cellulose purified talc purified water   starch sucrose titanium dioxide triethyl citrate - short term relief of constipation

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

viatris limited - bisacodyl 5mg - enteric coated tablet - 5 mg - active: bisacodyl 5mg excipient: carnauba wax hyprolose hypromellose methacrylic acid copolymer, eudragit s 100 iron oxide yellow isopropyl alcohol lactose monohydrate magnesium stearate   methacrylic acid copolymer microcrystalline cellulose purified talc purified water   starch sucrose titanium dioxide triethyl citrate - short term relief of constipation

Белгия - английски - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - bisacodyl 5 mg - coated tablet - 5 mg - bisacodyl 5 mg - bisacodyl

Белгия - английски - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - bisacodyl 10 mg - gastro-resistant tablet - 10 mg - bisacodyl 10 mg - bisacodyl

Кения - английски - Pharmacy and Poisons Board

gracure pharmaceuticals ltd e-i105 industrial area phase-iii bhiwadi - bisacodyl 5mg - tablet - bisacodyl 5mg - drugs for constipation: contact laxatives

Кения - английски - Pharmacy and Poisons Board

laboratory & allied ltd po box 42875-00100 nairobi - bisacodyl - tablet - bisacodyl 5mg per tablet - drugs for constipation: contact laxatives

САЩ - английски - NLM (National Library of Medicine)

lupin pharmaceuticals, inc. - bisacodyl (unii: 10x0709y6i) (deacetylbisacodyl - unii:r09078e41y) - bisacodyl 5 mg - gavilyte - h and bisacodyl delayed-release tablet, usp is indicated for cleansing of the colon as a preparation for colonoscopy in adults. the gavilyte - h and bisacodyl delayed-release tablet, usp is contraindicated in the following conditions: - gastrointestinal (gi) obstruction - bowel perforation - toxic colitis and toxic megacolon - gastric retention - ileus pregnancy category c animal reproduction studies have not been conducted. it is not known whether gavilyte - h and bisacodyl delayed-release tablet, usp can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. gavilyte - h and bisacodyl delayed-release tablet, usp should be given to a pregnant or nursing woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when gavilyte - h and bisacodyl delayed-release tablet, usp is administered to a nursing woman. safety and effectiveness in pediatric patients has

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

medreich plc - bisacodyl - gastro-resistant tablet - 5mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - bisacodyl - suppository - 10mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - bisacodyl - suppository - 10mg